Teva Pharmaceuticals will pay $420 million in a federal case
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva Pharmaceuticals - Wikipedia
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva_Pharmaceuticals | ערוץ 7
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva lied about opioid role, New York says | Reuters
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | The Seattle Times
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva agrees to $85 million settlement in opioid public nuisance case
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
